Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 32

1.

A Benefit Risk Review of Pediatric Use of Hydrocodone/Chlorpheniramine, a Prescription Opioid Antitussive Agent for the Treatment of Cough.

Sloan VS, Jones A, Maduka C, Bentz JWG.

Drugs Real World Outcomes. 2019 Jun;6(2):47-57. doi: 10.1007/s40801-019-0152-6. Review.

2.

Identifying Possible Outcome Domains from Existing Outcome Measures to Inform an OMERACT Core Domain Set for Safety in Rheumatology Trials.

Klokker L, Berthelsen DB, Woodworth T, Andersen KM, Furst DE, Devoe D, Williamson PR, Suarez-Almazor ME, Strand V, Leong AL, Goel N, Boers M, Brooks PM, March L, Sloan VS, Tugwell P, Simon LS, Christensen R.

J Rheumatol. 2019 May 1. pii: jrheum.190196. doi: 10.3899/jrheum.190196. [Epub ahead of print]

PMID:
31043547
3.

Opioid Use in Patients with Ankylosing Spondylitis Is Common in the United States: Outcomes of a Retrospective Cohort Study.

Sloan VS, Sheahan A, Stark JL, Suruki RY.

J Rheumatol. 2019 Jan 15. pii: jrheum.180972. doi: 10.3899/jrheum.180972. [Epub ahead of print]

4.

The Third Biennial 2018 OMERACT First-time Participant Program: A Qualitative and Quantitative Study.

Sloan VS, Grosskleg S, Wells G, Singh JA.

J Rheumatol. 2019 Aug;46(8):1036-1040. doi: 10.3899/jrheum.181196. Epub 2019 Jan 15.

PMID:
30647187
5.

The red thread.

Sloan VS.

Patient Educ Couns. 2018 Dec;101(12):2241-2242. doi: 10.1016/j.pec.2018.07.016. Epub 2018 Jul 25. No abstract available.

PMID:
30097379
6.

The OMERACT First-time Participant Program: Fresh Eye from the New Guys.

Sloan VS, Grosskleg S, Pohl C, Wells GA, Singh JA.

J Rheumatol. 2017 Oct;44(10):1560-1563. doi: 10.3899/jrheum.161119. Epub 2017 May 15.

PMID:
28507185
7.

Risk of QT prolongation and torsade de pointes associated with exposure to hydroxyzine: re-evaluation of an established drug.

Schlit AF, Delaunois A, Colomar A, Claudio B, Cariolato L, Boev R, Valentin JP, Peters C, Sloan VS, Bentz JWG.

Pharmacol Res Perspect. 2017 Apr 21;5(3):e00309. doi: 10.1002/prp2.309. eCollection 2017 Jun.

8.

The OMERACT First-time Participant ("Newbie") Program: Initial Assessment and Lessons Learned.

Sloan VS, Grosskleg S, Pohl C, Wells GA, Singh JA.

J Rheumatol. 2015 Oct;42(10):1976-1981. doi: 10.3899/jrheum.141200. Epub 2015 Jun 1.

PMID:
26034159
9.

A lesson from the slaughterhouse.

Sloan VS.

Ann Intern Med. 2012 Feb 21;156(4):328. doi: 10.7326/0003-4819-156-4-201202210-00026. No abstract available.

PMID:
22351726
10.

The anatomy professor.

Sloan VS.

J Gen Intern Med. 2012 Feb;27(2):260-1. doi: 10.1007/s11606-011-1824-4. No abstract available.

11.

Apremilast: a novel PDE4 inhibitor in the treatment of autoimmune and inflammatory diseases.

Schett G, Sloan VS, Stevens RM, Schafer P.

Ther Adv Musculoskelet Dis. 2010 Oct;2(5):271-8. doi: 10.1177/1759720X10381432.

12.

The content of their character.

Sloan VS.

Ann Intern Med. 2008 Jul 15;149(2):142-3. No abstract available.

PMID:
18626055
13.

Preliminary evidence for a structural benefit of the new bisphosphonate zoledronic acid in early rheumatoid arthritis.

Jarrett SJ, Conaghan PG, Sloan VS, Papanastasiou P, Ortmann CE, O'Connor PJ, Grainger AJ, Emery P.

Arthritis Rheum. 2006 May;54(5):1410-4.

14.

Cardiovascular safety of lumiracoxib: a meta-analysis of all randomized controlled trials > or =1 week and up to 1 year in duration of patients with osteoarthritis and rheumatoid arthritis.

Matchaba P, Gitton X, Krammer G, Ehrsam E, Sloan VS, Olson M, Mellein B, Hoexter G, Orloff J, Garaud JJ.

Clin Ther. 2005 Aug;27(8):1196-214. Review.

PMID:
16199245
15.

Lumiracoxib is effective in the treatment of osteoarthritis of the knee: a prospective randomized 13-week study versus placebo and celecoxib.

Fleischmann R, Sheldon E, Maldonado-Cocco J, Dutta D, Yu S, Sloan VS.

Clin Rheumatol. 2006 Feb;25(1):42-53. Epub 2005 Aug 13.

PMID:
16132165
16.

Efficacy and tolerability of lumiracoxib 100 mg once daily in knee osteoarthritis: a 13-week, randomized, double-blind study vs. placebo and celecoxib.

Lehmann R, Brzosko M, Kopsa P, Nischik R, Kreisse A, Thurston H, Litschig S, Sloan VS.

Curr Med Res Opin. 2005 Apr;21(4):517-26.

PMID:
15899100
17.
18.
19.

Efficacy of lumiracoxib in osteoarthritis: a review of nine studies.

Berenbaum F, Grifka J, Brown JP, Zacher J, Moore A, Krammer G, Dutta D, Sloan VS.

J Int Med Res. 2005 Jan-Feb;33(1):21-41.

PMID:
15651713
20.

Efficacy, safety and tolerability of lumiracoxib in patients with rheumatoid arthritis.

Geusens P, Alten R, Rovensky J, Sloan VS, Krammer G, Kralidis G, Richardson P.

Int J Clin Pract. 2004 Nov;58(11):1033-41.

PMID:
15605667
21.

Efficacy and safety of four doses of lumiracoxib versus diclofenac in patients with knee or hip primary osteoarthritis: a phase II, four-week, multicenter, randomized, double-blind, placebo-controlled trial.

Schnitzer TJ, Beier J, Geusens P, Hasler P, Patel SK, Senftleber I, Gitton X, Moore A, Sloan VS, Poór G.

Arthritis Rheum. 2004 Aug 15;51(4):549-57.

22.

Reiter syndrome following protracted symptoms of Cyclospora infection.

Sloan VS.

Emerg Infect Dis. 2001 Nov-Dec;7(6):1070. No abstract available.

23.

Death in springtime.

Sloan VS.

Ann Intern Med. 1999 Feb 2;130(3):243. No abstract available.

PMID:
10049213
24.

Reducing sleepiness on the roads and on the wards.

Sloan VS.

JAMA. 1999 Jan 13;281(2):134-5. No abstract available.

PMID:
9917113
25.

Classification of reactive arthritides.

Blumberg DR, Sloan VS.

Emerg Infect Dis. 1998 Jul-Sep;4(3):510-12. No abstract available.

26.

A potential mechanism of cyclosporine-associated bone pain: comment on the radiologic vignette by Stone et al.

O'Neill EA, Sloan VS.

Arthritis Rheum. 1998 Mar;41(3):565-6. No abstract available.

PMID:
9506589
27.

Aspirin in in-flight emergencies.

Sloan VS.

Ann Intern Med. 1998 Feb 15;128(4):326-7. No abstract available.

PMID:
9471949
28.

MHC and infectious diseases.

Sloan VS.

Emerg Infect Dis. 1997 Jul-Sep;3(3):407-8. No abstract available.

29.

Transgenic mouse models of experimental autoimmune encephalomyelitis.

Zaller DM, Sloan VS.

Curr Top Microbiol Immunol. 1996;206:15-31. Review. No abstract available.

PMID:
8608716
30.

Mediation by HLA-DM of dissociation of peptides from HLA-DR.

Sloan VS, Cameron P, Porter G, Gammon M, Amaya M, Mellins E, Zaller DM.

Nature. 1995 Jun 29;375(6534):802-6.

PMID:
7596415
31.

;He who saves a life saves a universe'.

Sloan VS.

West J Med. 1994 Nov;161(5):530. No abstract available.

32.

Sexual behavior in Peace Corps volunteers.

Sloan VS.

Arch Intern Med. 1992 May;152(5):1097. No abstract available.

PMID:
1533761

Supplemental Content

Loading ...
Support Center